Anna Farra
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 10
-
- Antimicrobial Resistance in Staphylococcus 4
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Bengt Wretlind (2 shared papers)G Kronvall (1 shared paper)Lars Sundström (1 shared paper)Malin Grape (1 shared paper)Mikael Sörberg (3 shared papers)Annelie Strålfors (1 shared paper)Sohidul Islam (1 shared paper)Bo Settergren (3 shared papers)
- Journals
- The Lancet (2 papers)Scandinavian Journal of Infectious Diseases (2 papers)Clinical Microbiology and Infection (2 papers)Frontiers in Cellular and Infection Microbiology (1 paper)The Lancet Global Health (1 paper)
- Partner nations
- LebanonUnited StatesSweden
In The Last Decade
Anna Farra
32 papers receiving 776 citations
Anna Farra's Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Medicine 195
- Applied Microbiology and Biotechnology 53
- Infectious Diseases 254
- Endocrinology 70
- Virology 61
Countries citing papers authored by Anna Farra
This map shows the geographic impact of Anna Farra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Farra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Farra more than expected).
Fields of papers citing papers by Anna Farra
This network shows the impact of papers produced by Anna Farra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Farra. The network helps show where Anna Farra may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Farra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 289 |
| 2 | 2005 | 83 | |
| 3 | 2006 | 69 | |
| 4 | 2008 | 63 | |
| 5 | 2023 | 42 | |
| 6 | 2016 | 38 | |
| 7 | 2013 | 28 | |
| 8 | 2015 | 22 | |
| 9 | 2012 | 18 | |
| 10 | 2003 | 15 | |
| 11 | 2002 | 15 | |
| 12 | 2018 | 14 | |
| 13 | 2002 | 14 | |
| 14 | 2005 | 13 | |
| 15 | 2018 | 12 | |
| 16 | 2022 | 10 | |
| 17 | 2008 | 9 | |
| 18 | 2017 | 9 | |
| 19 | 2022 | 7 | |
| 20 | 2022 | 6 |
About Anna Farra
Anna Farra is a scholar working on Molecular Medicine, Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology and Virology, having authored 36 papers that have together received 804 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antibiotic Use and Resistance (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), COVID-19 Clinical Research Studies (3 papers), Pneumonia and Respiratory Infections (3 papers), Genomics and Phylogenetic Studies (2 papers), Rabies epidemiology and control (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Molecular Medicine (195 citations), Applied Microbiology and Biotechnology (53 citations), Infectious Diseases (254 citations), Endocrinology (70 citations) and Virology (61 citations). Anna Farra has collaborated with scholars based in Lebanon, United States and Sweden. Frequent co-authors include Bengt Wretlind, G Kronvall, Lars Sundström, Malin Grape, Mikael Sörberg, Annelie Strålfors, Sohidul Islam, Bo Settergren, Katarina Westling and Krystel Moussally. Their work appears in journals such as The Lancet, Scandinavian Journal of Infectious Diseases, Clinical Microbiology and Infection, Frontiers in Cellular and Infection Microbiology and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.